Miragen Preps for Series B, Expects First IND in 2011

The expected size of the round is not being disclosed. The financing will be "just enough to support a couple programs moving forward and the continued operations of the company," Miragen President and CEO Bill Marshall said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories